News | Breast Density | February 20, 2019

Husband of late co-founder Nancy M. Cappello takes on leadership of advocacy organizations helping increase awareness of effects of breast density on mammography

Joseph J. Cappello Named Executive Director of Are You Dense Nonprofits

February 20, 2019 — The boards of Are You Dense Inc. and Are You Dense Advocacy Inc., founded by the late Nancy M. Cappello, Ph.D., announced her husband Joseph J. Cappello as their new executive director.  For over a decade, Joseph has worked side-by-side as co-founder of the organizations with his wife, earning him a unique perspective of the critical issue on adjunct screening for women with dense breast tissue.

“Duty compels me to carry on my wife’s mission,” said Cappello. “Women have the right to know their breast density status, to have their complete breast health information. This vital piece of information was denied to Nancy when she was originally diagnosed with late stage 3c breast cancer in 2004. As a result of her hard work, 36 states currently mandate physicians to tell their patients their breast density status.

“Now, we are focusing our energies on getting legislation passed in the remaining 14 states” Cappello added.

Science for decades has demonstrated that dense breast tissue is associated with a higher-than-average risk of breast cancer and that dense breast tissue can mask cancers on mammograms, making them impossible to detect. Adjunct screening to mammography, such as ultrasound and magnetic resonance imaging (MRI), significantly increase detection of early cancers in dense breasts.

Nancy Cappello launched the legislative action of her organizations after being diagnosed with advanced-stage breast cancer in 2004 despite decades of normal mammography results. None of her physicians told her that she had dense breast tissue, which had hidden the growing cancer in her breast, and none advised her to get adjunct screening. Her home state of Connecticut passed the first bill in 2009.

Nancy passed away in November due to complications from myelodysplastic syndrome (MDS), a rare form of bone marrow cancer that in some instances may be associated with previous radiation and chemotherapy cancer treatments.

“I am empowered and honored to further the Are You Dense? mission,” said Joseph Cappello, “that being to reduce missed, delayed and advanced stage breast cancer by increasing access to early detection for women with dense breasts leading to reduced harms from aggressive treatments and better survival outcomes.”

For more information: www.areyoudense.org, www.areyoudenseadvocacy.org


Related Content

News | Breast Imaging

June 25, 2025 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time June 25, 2025
arrow
News | Women's Health

June 23, 2025 — Susan G. Komen, the world’s leading breast cancer organization, recently announced it is awarding $10.8 ...

Time June 23, 2025
arrow
Feature | Women's Health | Christine Murray

In breast cancer detection, speed and accuracy are more than clinical goals – they can significantly increase chances ...

Time June 17, 2025
arrow
News | PET Imaging

May 30, 2025 — GE HealthCare recently announced that the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) ...

Time May 30, 2025
arrow
News | Imaging Software Development

May 27, 2025 — DeepLook Medical, a company advancing medical imaging through visual enhancement technology, recently ...

Time May 28, 2025
arrow
News | Breast Imaging

May 13, 2025 — In one of the larger studies of its kind, researchers have identified six breast texture patterns that ...

Time May 16, 2025
arrow
News | Mammography

April 29, 2025 — iCAD, a global provider of clinically proven AI-powered cancer detection solutions, has announced a ...

Time April 29, 2025
arrow
News | Mammography

April 24, 2025 — GE HealthCare will feature its latest advancements in diagnostic accuracy and patient-centered breast ...

Time April 24, 2025
arrow
News | Breast Imaging

March 20, 2025 — GE HealthCare has launched Invenia Automated Breast Ultrasound (ABUS) Premium, the latest 3D ultrasound ...

Time March 21, 2025
arrow
News | Artificial Intelligence

March 10, 2025 — Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, has published a ...

Time March 10, 2025
arrow
Subscribe Now